Press releases

GlaxoSmithKline UK Pharmaceuticals selects PHOENIX

GlaxoSmithKline UK Pharmaceuticals selects PHOENIX in new Reduced Wholesale Model distribution agreement

GSK UK Pharmaceuticals are changing the distribution model for medicines from the current Direct to Pharmacy model to a Reduced Wholesaler model, from 1st November 2018.

In a Reduced Wholesaler model, GSK will sell products to PHOENIX, which means our customers will have access to GSK’s prescription portfolio.

Therefore from 1st November 2018, you can place your orders for GSK’s prescription portfolio through PHOENIX.